BioSpace News Archive

12 leading associations and non-profits representing patients, clinicians, hospitals, health plans, and technology companies released a white paper highlighting their shared commitment to supporting patients in accessing and using their health information.

- The following quote is attributed to Susan Mayne , Ph.D., director of the Center for Food Safety and Applied Nutrition “The FDA is committed to keeping consumers safe from potentially contaminated cosmetic products. As part of this effort, in September 2018 , the agency awarded AMA Analytical Services, Inc. (AMA) a on

A national medical society on Sunday recognized a study from the JFK Johnson Stroke-HEART™ Trials as the best research published last year in the field’s most prestigious journal.

COCRYSTAL PHARMA, INC. announced that it has entered into definitive agreements with several institutional investors for the purchase of 5,037,038 shares of its common stock at a price of $1.35 per share, for aggregate gross proceeds of approximately $6.8 million, in a registered direct offering priced at-the-market under Nasdaq rules.

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Brinda Balakrishnan , M.D., Ph.D., has been named to the San Francisco Business Times 2020 “40 Under 40" list. Now in its ninth year, the San Francisco Business Times “40 Under 40" list highlights the Bay Area’s best and brightest young business and community le

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced their upcoming webinar, “Translational Modeling Strategies to Predict Clinical Doses for CD3 Bispecific Molecules’’ occurs Thursday, March 12, 2020 at 2p.m. ET / 11a.m. PT.

Vectura Group plc (LSE: VEC) (“Vectura”, “the Company” or “the Group”) today announced a key leadership appointment to drive business development and growth as the Company continues with its strategy to become a leading inhalation specialist in the pharmaceutical services space.

F2G Ltd, a UK- and Austria-based biotech developing novel therapies for life-threatening systemic fungal infections, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead first-in-class candidate, olorofim (formerly F901318) for “treatment of invasive aspergillosis” and for “treatment of lomentospora/scedosporium infections”[1], which are invasive mould infections, for which there is significant unmet medical need.

The Branford Group, a Global Industrial Auction Company, in conjunction with Prestige Auctions will conduct a series of 2 Online Auctions to sell the assets of formerly Micro Machine Company located at 2429 N. Burdick Street, Kalamazoo, MI & 4130 Corridor Drive, Warsaw, IN..

Altima Dental is celebrating a record-breaking year after increasing the total number of dental clinics by 60% and adding over $160 million in partnership value in 2019.